Pacific Biosciences of California, Inc. Shareholders' Equity
Pacific Biosciences of California, Inc. (PACB) had Shareholders' Equity of -$33.21 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$33.21M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.37M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.35M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $36.09M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$33.21M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.37M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $5.35M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $36.09M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $61.49M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $91.64M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $506.59M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $453.12M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $492.70M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $649.02M 10-Q · filed 2025-08-07 |
| 2023-12-31 | $701.30M 10-K · filed 2026-02-25 |
| 2023-09-30 | $763.74M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $642.00M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $692.12M 10-Q · filed 2024-08-09 |
| 2022-12-31 | $562.90M 10-K · filed 2026-02-25 |
| 2022-09-30 | $626.59M 10-Q · filed 2023-11-03 |
| 2022-06-30 | $681.89M 10-Q · filed 2023-11-03 |
| 2022-03-31 | $734.58M 10-Q · filed 2023-08-04 |
| 2021-12-31 | $790.99M 10-K · filed 2025-03-17 |
| 2021-09-30 | $840.81M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $258.25M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $280.55M 10-Q · filed 2022-08-08 |
| 2020-12-31 | $335.49M 10-K · filed 2024-02-28 |
| 2020-09-30 | $129.50M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $41.39M 10-Q · filed 2021-11-05 |
| 2020-03-31 | $60.40M 10-Q · filed 2021-08-06 |
| 2019-12-31 | $54.92M 10-K · filed 2023-02-28 |
| 2019-09-30 | $51.01M 10-Q · filed 2020-11-03 |
| 2019-06-30 | $75.75M 10-Q · filed 2020-11-03 |
| 2019-03-31 | $94.85M 10-Q · filed 2020-08-06 |
| 2018-12-31 | $114.06M 10-K · filed 2022-02-28 |
| 2018-09-30 | $131.88M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $85.47M 10-Q · filed 2019-11-07 |
| 2018-03-31 | $102.74M 10-Q · filed 2019-08-06 |
| 2017-12-31 | $86.10M 10-K · filed 2021-02-26 |
| 2017-09-30 | $101.41M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $115.86M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $69.19M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $84.67M 10-K · filed 2020-02-28 |
| 2016-09-30 | $98.68M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $108.07M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $88.78M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $73.54M 10-K · filed 2019-02-26 |
| 2015-09-30 | $41.37M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $33.84M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $40.47M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $54.95M 10-K · filed 2018-02-26 |
| 2014-09-30 | $53.03M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $59.02M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $75.53M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $69.18M 10-K · filed 2017-03-06 |
| 2013-09-30 | $83.54M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $100.40M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $107.09M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $109.38M 10-K · filed 2016-03-11 |
| 2012-09-30 | $128.54M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $148.20M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $167.90M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $191.46M 10-K · filed 2015-03-12 |
| 2011-09-30 | $210.68M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $233.33M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $279.87M 10-K · filed 2014-03-14 |
| 2009-12-31 | -$177.12M 10-K · filed 2013-03-15 |
| 2008-12-31 | -$93.39M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |